M&A-led growth, $1B+ backlog and data center demand—plus margin, cash flow and leverage risks. Click for more on FPS stock.
Initial public offering listings rebounded last year, though their performance—and a government shutdown—held back some ...
After euphoric listings and sharp corrections, can India’s IPO market recalibrate valuations, protect retail capital, and ...
Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback